SE514128C2 - Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit - Google Patents

Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit

Info

Publication number
SE514128C2
SE514128C2 SE9800905A SE9800905A SE514128C2 SE 514128 C2 SE514128 C2 SE 514128C2 SE 9800905 A SE9800905 A SE 9800905A SE 9800905 A SE9800905 A SE 9800905A SE 514128 C2 SE514128 C2 SE 514128C2
Authority
SE
Sweden
Prior art keywords
use according
medicament
glucocorticoid
treatment
glomerulonephritis
Prior art date
Application number
SE9800905A
Other languages
English (en)
Swedish (sv)
Other versions
SE9800905L (sv
SE9800905D0 (sv
Inventor
Roger Haellgren
Bengt Fellstroem
Original Assignee
Pharmalink Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmalink Ab filed Critical Pharmalink Ab
Priority to SE9800905A priority Critical patent/SE514128C2/sv
Publication of SE9800905D0 publication Critical patent/SE9800905D0/xx
Priority to US09/266,023 priority patent/US6239120B1/en
Priority to AT99910932T priority patent/ATE224195T1/de
Priority to JP2000536384A priority patent/JP4326696B2/ja
Priority to CNB998041351A priority patent/CN1152688C/zh
Priority to BR9908838-0A priority patent/BR9908838A/pt
Priority to DE69902999T priority patent/DE69902999T2/de
Priority to ES99910932T priority patent/ES2181407T3/es
Priority to EP99910932A priority patent/EP1056461B1/de
Priority to KR1020007009283A priority patent/KR20010041204A/ko
Priority to CA002317796A priority patent/CA2317796A1/en
Priority to AU29686/99A priority patent/AU749199B2/en
Priority to PCT/SE1999/000406 priority patent/WO1999047144A1/en
Publication of SE9800905L publication Critical patent/SE9800905L/
Publication of SE514128C2 publication Critical patent/SE514128C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SE9800905A 1998-03-17 1998-03-17 Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit SE514128C2 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE9800905A SE514128C2 (sv) 1998-03-17 1998-03-17 Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
US09/266,023 US6239120B1 (en) 1998-03-17 1999-03-11 Method and means for treating glomerulonephritis
PCT/SE1999/000406 WO1999047144A1 (en) 1998-03-17 1999-03-16 Method and means for treating glomerulonephritis
DE69902999T DE69902999T2 (de) 1998-03-17 1999-03-16 Glucocorticoide zur behandlung von glomerulonephitis
JP2000536384A JP4326696B2 (ja) 1998-03-17 1999-03-16 糸球体腎炎の治療のための方法および手段
CNB998041351A CN1152688C (zh) 1998-03-17 1999-03-16 糖皮质激素用于制备治疗肾小球肾炎的药剂的用途及该药剂用于治疗IgA 肾病的用途
BR9908838-0A BR9908838A (pt) 1998-03-17 1999-03-16 Uso de um glicocorticóide, processeo para tratar glomerulonefrite aguda ou crÈnica, e, composição farmacêutica para tratar glomerulonefrite
AT99910932T ATE224195T1 (de) 1998-03-17 1999-03-16 Glucocorticoide zur behandlung von glomerulonephitis
ES99910932T ES2181407T3 (es) 1998-03-17 1999-03-16 Glucocorticoides para tratar la glomerulonefritis.
EP99910932A EP1056461B1 (de) 1998-03-17 1999-03-16 Glucocorticoide zur behandlung von glomerulonephitis
KR1020007009283A KR20010041204A (ko) 1998-03-17 1999-03-16 사구체신염의 치료 방법 및 수단
CA002317796A CA2317796A1 (en) 1998-03-17 1999-03-16 Method and means for treating glomerulonephritis
AU29686/99A AU749199B2 (en) 1998-03-17 1999-03-16 Method and means for treating glomerulonephritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9800905A SE514128C2 (sv) 1998-03-17 1998-03-17 Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit

Publications (3)

Publication Number Publication Date
SE9800905D0 SE9800905D0 (sv) 1998-03-17
SE9800905L SE9800905L (sv) 1999-09-18
SE514128C2 true SE514128C2 (sv) 2001-01-08

Family

ID=20410600

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9800905A SE514128C2 (sv) 1998-03-17 1998-03-17 Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit

Country Status (12)

Country Link
EP (1) EP1056461B1 (de)
JP (1) JP4326696B2 (de)
KR (1) KR20010041204A (de)
CN (1) CN1152688C (de)
AT (1) ATE224195T1 (de)
AU (1) AU749199B2 (de)
BR (1) BR9908838A (de)
CA (1) CA2317796A1 (de)
DE (1) DE69902999T2 (de)
ES (1) ES2181407T3 (de)
SE (1) SE514128C2 (de)
WO (1) WO1999047144A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
CA2538202C (en) * 2003-09-15 2013-01-15 Altana Pharma Ag Use of ciclesonide for the treatment of inflammatory bowel diseases
GB0808537D0 (en) * 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
JP7376582B2 (ja) * 2018-10-22 2023-11-08 イーオーイー オレオ ゲーエムベーハー 成形体への圧縮を目的とした粉末材料用添加剤
US11896719B2 (en) * 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease

Also Published As

Publication number Publication date
AU2968699A (en) 1999-10-11
WO1999047144A1 (en) 1999-09-23
ATE224195T1 (de) 2002-10-15
EP1056461B1 (de) 2002-09-18
KR20010041204A (ko) 2001-05-15
DE69902999T2 (de) 2003-06-05
JP4326696B2 (ja) 2009-09-09
JP2002506824A (ja) 2002-03-05
SE9800905L (sv) 1999-09-18
BR9908838A (pt) 2000-12-12
AU749199B2 (en) 2002-06-20
EP1056461A1 (de) 2000-12-06
ES2181407T3 (es) 2003-02-16
CN1152688C (zh) 2004-06-09
CN1293572A (zh) 2001-05-02
CA2317796A1 (en) 1999-09-23
DE69902999D1 (de) 2002-10-24
SE9800905D0 (sv) 1998-03-17

Similar Documents

Publication Publication Date Title
Bergmann et al. Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation
AU643021B2 (en) Oral composition for the treatment of inflammatory bowel diseases
EP3936133A1 (de) Natürliche kombinationshormonersatzformulierungen und therapien
EP1991270A2 (de) Zusammensetzungen und verfahren für die prophylaxe und therapie von kachexie
WO2007095497A2 (en) Compositions and methods for prevention and treatment of cachexia
KR102537990B1 (ko) 스테로이드 용량의 감소 및 염증과 자가면역 질환의 치료를 위한 칸나비디올
AU2019404026B2 (en) Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound
TWI452032B (zh) 治療腎病之醫藥組成物
WO1997034605A1 (en) Use of nicotine to treat liver disease
US6239120B1 (en) Method and means for treating glomerulonephritis
US6096731A (en) Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation
SE514128C2 (sv) Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
US20080262071A1 (en) Pindolol for the Treating Premenstrual Syndrome and Premenstrual Dysphoric Disorder
WO2009080030A1 (en) Treatment of autoimmune hepatitis with a once daily oral dosage form comprising tacrolimus
US20100184732A1 (en) Method of long-term treatment of graft-versus-host disease using topical active corticosteroids
EP1793818A2 (de) Pindolol zur behandlung des prämenstruellen syndroms und von prämenstrueller dysphorie
MXPA00008173A (en) Method and means for treating glomerulonephritis
US20020086857A1 (en) Method of long-term treatment of graft-versus-host disease using topical active corticosterioids
CA2413883C (en) Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation
Burggraaf et al. The gastrointestinal passage and release of beclomethasone dipropionate from oral delivery systems in ileostomy volunteers
US20030004214A1 (en) Use of rofleponide in the treatment of irritable bowel syndrome (ibs)
JP2005097220A (ja) 後腹膜線維症治療剤
US20140328929A1 (en) Method of Preventing Acute Graft-Versus-Host Disease using Oral Beclomethasone Dipropionate
WO2001003703A1 (en) An oral composition having as a first active ingredient rofleponide and as a second active ingredient an antibiotic, for use in intestinal conditions, especially crohn's disease
TW200840590A (en) Compositions and methods for prevention and treatment of cachexia

Legal Events

Date Code Title Description
NUG Patent has lapsed